Purdue High School Lands Temporary Home

Posted: Updated:
(photo courtesy Purdue University) (photo courtesy Purdue University)
INDIANAPOLIS -

The building that served as the former home of Manual and Wood high schools will be the temporary home of the new Purdue Polytechnic High School in Indianapolis. The Union 525 will house the school during the 2017-2018 academic year while renovation work on the school's permanent home continues.

Purdue announced in October the STEM-focused charter school will be located in the PR Mallory building on the east side of Indianapolis. A time frame for the completion of renovations to the abandoned complex was not given.

Purdue says Union 525 is a perfect fit for PPHS as it already houses tech companies and its downtown Indianapolis location is close to the school's industry partners. 

"This will be a tremendous location for us to begin our exciting work," said Scott Bess, head of the Polytechnic High School. "We were able to find a downtown site that meets all of our needs and that has such a rich history in preparing students through technical and STEM-related education."

The application period for PPHS closed earlier this month and Purdue says the number of applications outpaced the 150 available slots. School officials expect to have final enrollment information for the inaugural freshman class compiled by late spring.

  • Perspectives

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    More

Events



  • Most Popular Stories

    • $25M Behavioral Hospital Coming to Central Indiana

      Danville-based Hendricks Regional Health is partnering with US HealthVest to develop a stand-alone behavioral center on the Hendricks campus in Plainfield. Known as the Indianapolis Behavioral Hospital, the facility will provide specialized inpatient and outpatient mental health care to patients of all ages.

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    • Christel DeHaan to Retire as Christel House CEO

      One of the biggest names in philanthropy in Indiana is announcing her retirement. Christel House International Chief Executive Officer Christel DeHaan will remain board chair, but leave as CEO of the nonprofit she founded 20 years ago. The organization has named former Indianapolis Mayor Bart Peterson to be her successor. CHI's mission is to lift children out of poverty, and it has established learning centers at home in Indianapolis and abroad in Mexico, India, South Africa and...

    • Sturges, CBRE Splitting Up

      A long-time commercial real estate firm in Fort Wayne is going independent. CBRE | Sturges, which became affiliated with the global brand more than 20 years ago, will become Sturges Property Group at the end of this month. The firm was founded in 1975 and bills itself as largest full-service commercial and industrial real estate firm in the region. The shift, Sturges says, will...

    • Endocyte, Novartis Ink $2.1B Merger Agreement

      West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) has announced a merger agreement with a global pharmaceutical giant. The deal with Switzerland-based Novartis AG is valued at $2.1 billion and still requires shareholder approval. Until regulatory and other approvals are met, Endocyte will remain independent. The proposed merger of Endocyte into Novartis is slated to be complete in the first half of next year. Endocyte develops targeted cancer therapies and earlier this...